# Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms

> **NCT03345329** · — · COMPLETED · sponsor: **General Biologicals Corporation** · enrollment: 100 (actual)

## Conditions studied

- Periodontal Diseases
- Peri-Implantitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03345329
- **Lead sponsor:** General Biologicals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-01
- **Primary completion:** 2016-03-30
- **Final completion:** 2016-09-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03345329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03345329, "Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03345329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*